Innoviva appoints Stephen Basso as CFO with $450K salary, $100K signing bonus

Innoviva, Inc.

Stephen Basso appointed CFO effective August 21, 2023; brings 30+ years pharma/finance leadership experience.
Base salary $450K, target annual bonus 40% of base, one-time $100K signing bonus (repayable if leaves within 1 year for cause).
Initial grant of 150,000 nonqualified stock options; vesting 25% on 1st anniversary, then quarterly over 3 years.
Severance: 12 months salary continuation, COBRA, and accelerated vesting on change-in-control termination without cause or for good reason.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stephen Basso

Chief Financial Officer

INVA · Innoviva, Inc.

Effective: 2023-08-21
Filed: August 25, 2023, 7:59 PM ET

On August 25, 2023, Innoviva, Inc. (the “Company”) announced the hiring and appointment of Stephen Basso, age 57, Chief Financial Officer of the Company, effective as of August 21, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Stephen Basso was appointed as Chief Financial Officer at Innoviva, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On August 25, 2023, Innoviva, Inc. (the “Company”) announced the hiring and appointment of Stephen Basso, age 57, Chief Financial Officer of the Company, effective as of August 21, 2023.

View on SEC.gov

Innoviva, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-095406

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.